Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

JCO Early Release, published online ahead of print Dec 19 2011
Journal of Clinical Oncology, 10.1200/JCO.2011.36.8571

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deprez, S.
Right arrow Articles by Sunaert, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deprez, S.
Right arrow Articles by Sunaert, S.
Related Articles
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Delicious   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

  • "Doctor, Will the Treatment You Are Recommending Cause Chemobrain?"
    Patricia A. Ganz
    JCO 2012 30: 229-231 [Full Text]


This article has been cited by other articles:


Home page
Cancer Res.Home page
G. S. Chiu, M. A. Maj, S. Rizvi, R. Dantzer, E. G. Vichaya, G. Laumet, A. Kavelaars, and C. J. Heijnen
Pifithrin-{mu} Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function
Cancer Res., February 1, 2017; 77(3): 742 - 752.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
R. Yamanaka, K. Morii, M. Sano, J. Homma, N. Yajima, Y. Tsukamoto, R. Ogura, M. Natsumeda, H. Aoki, K. Akiyama, et al.
Long-term survivors of primary central nervous system lymphoma
Jpn. J. Clin. Oncol., November 23, 2016; (2016) hyw171v1.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Lange, N. Heutte, O. Rigal, S. Noal, J.-E. Kurtz, C. Levy, D. Allouache, C. Rieux, J. Lefel, B. Clarisse, et al.
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment
Oncologist, November 1, 2016; 21(11): 1337 - 1348.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. P. Taylor
Comment: Chemoradiotherapy for glioblastoma patients--The double-edged sword
Neurology, August 25, 2015; 85(8): 689 - 689.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Prust, K. Jafari-Khouzani, J. Kalpathy-Cramer, P. Polaskova, T. T. Batchelor, E. R. Gerstner, and J. Dietrich
Standard chemoradiation for glioblastoma results in progressive brain volume loss
Neurology, August 25, 2015; 85(8): 683 - 691.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
K. Hermelink
Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain
J Natl Cancer Inst Monographs, May 1, 2015; 2015(51): 67 - 69.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Natori, T. Ogata, M. Sumitani, T. Kogure, T. Yamauchi, and H. Yamauchi
Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment
Clin. Cancer Res., March 15, 2015; 21(6): 1348 - 1352.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
C. S. Denlinger, J. A. Ligibel, M. Are, K. S. Baker, W. Demark-Wahnefried, D. L. Friedman, M. Goldman, L. Jones, A. King, G. H. Ku, et al.
Survivorship: Cognitive Function, Version 1.2014
J Natl Compr Canc Netw, July 1, 2014; 12(7): 976 - 986.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Deprez, M. Vandenbulcke, R. Peeters, L. Emsell, A. Smeets, M.-R. Christiaens, F. Amant, and S. Sunaert
Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive Complaints
J. Clin. Oncol., July 1, 2014; 32(19): 2031 - 2038.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
G. Pereira Dias, R. Hollywood, M. C. d. N. Bevilaqua, A. C. D. da Silveira da Luz, R. Hindges, A. E. Nardi, and S. Thuret
Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms
Neuro Oncology, April 1, 2014; 16(4): 476 - 492.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. Schuitema, S. Deprez, W. Van Hecke, M. Daams, A. Uyttebroeck, S. Sunaert, F. Barkhof, E. van Dulmen-den Broeder, H. J. van der Pal, C. van den Bos, et al.
Accelerated Aging, Decreased White Matter Integrity, and Associated Neuropsychological Dysfunction 25 Years After Pediatric Lymphoid Malignancies
J. Clin. Oncol., September 20, 2013; 31(27): 3378 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. Kesler, J. S. Wefel, S. M. H. Hosseini, M. Cheung, C. L. Watson, and F. Hoeft
Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls
PNAS, July 9, 2013; 110(28): 11600 - 11605.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. D. Doolittle, A. Korfel, M. A. Lubow, E. Schorb, U. Schlegel, S. Rogowski, R. Fu, E. Dosa, G. Illerhaus, D. F. Kraemer, et al.
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma
Neurology, July 2, 2013; 81(1): 84 - 92.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. A. Ganz, L. Kwan, S. A. Castellon, A. Oppenheim, J. E. Bower, D. H. S. Silverman, S. W. Cole, M. R. Irwin, S. Ancoli-Israel, and T. R. Belin
Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance
J Natl Cancer Inst, June 5, 2013; 105(11): 791 - 801.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
J. C. Holland, B. Andersen, W. S. Breitbart, L. O. Buchmann, B. Compas, T. L. Deshields, M. M. Dudley, S. Fleishman, C. D. Fulcher, D. B. Greenberg, et al.
Distress Management
J Natl Compr Canc Netw, February 1, 2013; 11(2): 190 - 209.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. A. Ahles, J. C. Root, and E. L. Ryan
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
J. Clin. Oncol., October 20, 2012; 30(30): 3675 - 3686.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. C. McDonald, S. K. Conroy, T. A. Ahles, J. D. West, and A. J. Saykin
Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study
J. Clin. Oncol., July 10, 2012; 30(20): 2500 - 2508.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. A. Ganz
"Doctor, Will the Treatment You Are Recommending Cause Chemobrain?"
J. Clin. Oncol., January 20, 2012; 30(3): 229 - 231.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2011 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online